Search for other papers by Zohar Steinberg Ben-Zeev in
Google Scholar
PubMed
Search for other papers by Marina Peniakov in
Google Scholar
PubMed
Search for other papers by Clari Felszer in
Google Scholar
PubMed
Search for other papers by Scott A Weiner in
Google Scholar
PubMed
Search for other papers by Avishay Lahad in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
The Rappaport Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum Rakover in
Google Scholar
PubMed
Introduction Maternal thyroid diseases are considered a risk factor for abnormal thyroid function at birth ( 1 , 2 , 3 , 4 , 5 ), as well as for long-term morbidity in offspring ( 1 , 6 , 7 , 8 , 9 , 10 , 11 ). Maternal
Search for other papers by Marco Capezzone in
Google Scholar
PubMed
Search for other papers by Noemi Fralassi in
Google Scholar
PubMed
Search for other papers by Chiara Secchi in
Google Scholar
PubMed
Search for other papers by Silvia Cantara in
Google Scholar
PubMed
Search for other papers by Lucia Brilli in
Google Scholar
PubMed
Search for other papers by Tania Pilli in
Google Scholar
PubMed
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Raffaella Forleo in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Gabriele Cevenini in
Google Scholar
PubMed
Search for other papers by Alessandra Cartocci in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
, et al. Endocrine tumours: familial nonmedullary thyroid carcinoma is a more aggressive disease: a systematic review and meta-analysis . Eur J Endocrinol . 2015 Jun ; 172 ( 6 ): R253 – 62 . 10.1530/EJE-14-0960 25637073 0804-4643 14
Search for other papers by R. Paschke in
Google Scholar
PubMed
Search for other papers by M. Niedziela in
Google Scholar
PubMed
Search for other papers by B. Vaidya in
Google Scholar
PubMed
Search for other papers by L. Persani in
Google Scholar
PubMed
Search for other papers by B. Rapoport in
Google Scholar
PubMed
Search for other papers by J. Leclere in
Google Scholar
PubMed
Introduction Familial non-autoimmune autosomal dominant hyperthyroidism (FNAH) and persistent sporadic congenital non-autoimmune hyperthyroidism (PSNAH) are rare forms of hyperthyroidism caused by germline mutations in the thyroid
Search for other papers by Elena Sabini in
Google Scholar
PubMed
Search for other papers by Ilaria Ionni in
Google Scholar
PubMed
Search for other papers by Roberto Rocchi in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Michele Marinò in
Google Scholar
PubMed
orbitopathy, he was hit in his right eye by a tennis ball while playing on the beach. He had a familial history of thyroid autoimmunity, as his mother had autoimmune thyroiditis. He had no relevant associated diseases and was a smoker (∼10 cigarettes/day since
Search for other papers by Giovanni de Gennaro in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Michele Marinò in
Google Scholar
PubMed
What Is Known about This Topic? Oculocutaneous albinism is a heterogeneous autosomal recessive disorder characterized by reduced or absent melanin synthesis. To our knowledge, the coexistence of albinism and autoimmune thyroid diseases has
Search for other papers by Pauline Campredon in
Google Scholar
PubMed
Multidisciplinary Thyroid Eye Consultation, Department of Endocrinology, Larrey University Hospital, Toulouse, France
Search for other papers by Philippe Imbert in
Google Scholar
PubMed
Search for other papers by Céline Mouly in
Google Scholar
PubMed
Search for other papers by Solange Grunenwald in
Google Scholar
PubMed
Search for other papers by Julien Mazières in
Google Scholar
PubMed
Search for other papers by Philippe Caron in
Google Scholar
PubMed
. The patient had no history of familial or personal thyroid disease, and he was euthyroid prior to nivolumab therapy. Physical examination showed bilateral eyelid ptosis and bilateral conjunctival redness with chemosis, which was more severe in the left
Search for other papers by Francesca Orsolini in
Google Scholar
PubMed
Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Search for other papers by Pierpaolo Falcetta in
Google Scholar
PubMed
Search for other papers by Domenico Canale in
Google Scholar
PubMed
Search for other papers by Fulvio Basolo in
Google Scholar
PubMed
Search for other papers by Greta Alì in
Google Scholar
PubMed
Search for other papers by Francesca Manassero in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia 2A (MEN2A) syndrome is an autosomal dominant disorder that includes medullary thyroid carcinoma (MTC), pheochromocytoma and hyperparathyroidism. MTC is the most common manifestation (90–100%) of MEN2A
Search for other papers by Clotilde Saïe in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Samir Saheb in
Google Scholar
PubMed
Search for other papers by Christel Jublanc in
Google Scholar
PubMed
Search for other papers by Denis Lemesle in
Google Scholar
PubMed
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Fabrice Menegaux in
Google Scholar
PubMed
Search for other papers by Christophe Tresallet in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
) is an effective blood purification procedure used to treat various disorders such as autoimmune diseases and familial hypercholesterolemia [ 2 ]. In hyperthyroidism, TPE has been used since 1970 [ 3 ] and is mainly considered for use in clinical
Search for other papers by Rima Bėrontienė in
Google Scholar
PubMed
Search for other papers by Edita Jašinskienė in
Google Scholar
PubMed
Search for other papers by Rosita Kiudelienė in
Google Scholar
PubMed
Search for other papers by Gintaras Kuprionis in
Google Scholar
PubMed
Search for other papers by Jurgita Makštienė in
Google Scholar
PubMed
Search for other papers by Raminta Macaitytė in
Google Scholar
PubMed
Search for other papers by Dalia Marčiulionytė in
Google Scholar
PubMed
Search for other papers by Lina Poškienė in
Google Scholar
PubMed
Search for other papers by Agnė Šemetaitė in
Google Scholar
PubMed
Search for other papers by Vygantas Šidlauskas in
Google Scholar
PubMed
Search for other papers by Raimondas Valickas in
Google Scholar
PubMed
Search for other papers by Rimantas Žalinkevičius in
Google Scholar
PubMed
Institute of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania
Search for other papers by Rasa Verkauskienė in
Google Scholar
PubMed
radioiodine after the Chornobyl accident. Br J Cancer 2011;104:181-187. 13 Niedziela M, Korman E, Breborowicz D, Trejster E, Harasymczuk J, Warzywoda M, Rolski M, Breborowicz J: A prospective study of thyroid nodular disease in children and adolescents
Search for other papers by Marta Nascimento Soares in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Department of Surgery and Physiology, Cardiovascular Research Unit, Faculty of Medicine from the University of Porto, Porto, Portugal
Search for other papers by Marta Borges-Canha in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Institute for Research Innovation in Health, University of Porto, Porto, Portugal
Search for other papers by Celestino Neves in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Department of Surgery and Physiology, Cardiovascular Research Unit, Faculty of Medicine from the University of Porto, Porto, Portugal
Search for other papers by João Sérgio Neves in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Institute for Research Innovation in Health, University of Porto, Porto, Portugal
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Introduction Graves' disease is an autoimmune thyroid disease, being the most frequent cause of hyperthyroidism ( 1 ). It is caused by the production of autoantibodies (thyrotropin receptor antibodies (TRAbs)) against the thyrotropin receptor